ArticleFrontiers in molecular biosciences2026
Next-generation viral detection through AI-enhanced nanotechnology: advances, challenges, and future directions.
Article in Frontiers in molecular biosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Emerging viral outbreaks, such as the COVID-19 pandemic, have highlighted the critical need for rapid, accurate, and scalable virus detection systems. This review aims to explore the integration of artificial intelligence (AI) and nanotechnology as a transformative approach for real-time virus prediction, monitoring, and management. The review systematically analyzes how machine learning (ML) and deep learning (DL) algorithms are being applied to identify viral mutations, forecast outbreak trajectories, and analyze complex virological data. It also highlights recent advances in nanotechnology, including the development of nanosensors, nanoparticle-based diagnostics, and lab-on-chip devices. The synergy between AI and nanotechnology is examined through selected case studies and near-real-world implementation efforts. The convergence of AI and nanotechnology represents a promising translational pipeline toward highly sensitive, rapid, and personalized viral detection systems, with substantial clinical validation and regulatory maturation still required before routine deployment. When combined, AI enhances the interpretability and responsiveness of nanotech-based diagnostics, while nanodevices provide high-resolution data for AI-driven prediction models. This integration supports more adaptive, data-driven public health responses. This review presents an up-to-date, interdisciplinary overview of AI-nanotech integration in virology. It identifies current challenges such as data privacy, algorithmic bias, and regulatory barriers, while proposing future directions for personalized and globally inclusive virus surveillance systems. The combined power of biological insight and technological innovation outlines an emerging paradigm for managing viral threats, contingent upon continued translational validation and real-world implementation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.